These glioma‐supplied cytokines were also responsible for changing the transcriptomic profile of surviving TAMs, reprogramming them toward a less pro‐tumoral phenotype by reducing the polarization of M2 macrophages in gliomas treated with CSF‐1R inhibitor. The gene discussed is CSF1R; the disease is glioma.